AstraZeneca Says Type 2 Diabetes Treatment Xigduo Has Got EU Approval
LONDON (Alliance News) - AstraZeneca PLC Wednesday said the Xigduo treatment it developed with Bristol-Myers Squibb as part of their diabetes collaboration, has been approved in the European Union as a treatment for Type 2 Diabetes. Xigduo is indicated for adults aged 18 and older with type Read More